Merian Asia Pacific Fund R GBP Acc
New for 2018. Uses numbers-driven investment process
This fund is run by a trio of fund managers who run another two Rated Funds in different sectors. Ian Heslop, Amadeo Alentorn and Mike Servent have run Old Mutual Global Equity and Old Mutual North American Equity since 2004 and have managed Old Mutual Asia Pacific since 2011.All of their funds are very well-diversified – the US fund had more than 450 holdings at the end of 2017, while the US and Asia Pacific funds had more than 200.
Heslop, head of global equities at Old Mutual Global Investors, has devised an investment process based on algorithms. He believes it is too difficult to forecast what is going to happen in the stock market, even if you correctly predict macroeconomic events. He and his team use this numbers-driven investment process to make investment decisions based on objective criteria. They look for the types of stocks that other investors are buying, and then look for the best companies they can buy to take advantage of these themes. In other words, they seek to 'follow the money'. It is an approach that recognises the cyclicality of investment processes and adjusts exposures to take advantage of prevailing market conditions. Recent performance has benefited from having a third of their Old Mutual Asia Pacific fund in technology stocks.
Heslop believes that in general, there are more inefficiencies to be exploited in the Asia Pacific region compared to the other markets in which they invest, and judging by the fund's stellar performance, he is right on the money.
Narrative and ratings content all as of 01 January 2018.See all Money Observer rated funds
Dr. Ian Heslop is the Deputy Head of Quantitative Strategies at Old Mutual Asset Managers (UK). He joined the Quantitative Strategies team in June 2004 from OMAM's Global Equities team, where he was a fund manager specialising in the global technology and biotechnology sectors. He joined the Old Mutual group from Barclays Global Investors, where he was a UK quantitative fund manager (1997-2000). Ian has a BA in Chemistry from Oxford University (1993) and a PhD in Medicinal Chemistry from Edinburgh University (1997).
Data provided by Morningstar.
The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Money Observer and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.
This information is sourced from our partner Morningstar. We believe the data to be correct however you should take care in using any information.
You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.